Clinic for Visceral Medicine and Surgery, Department of Hepatology, Inselspital Bern, Bern, Switzerland.
Charité - Universitätsmedizin Berlin, Berlin, Germany.
Department of Cardiology, Inselspital Bern, Bern, Switzerland.
Department of Nephrology, Inselspital Bern, Bern, Switzerland.
A sofosbuvir/ledipasvir combination is part of a first-line treatment of hepatitis C. However, in patients concurrently treated with amiodarone, cardiac side effects have been described, resulting in an official warning in 2015 by the American Food and Drug Administration and the European Medicines Agency when combining those substances. This deprived numerous hepatitis C patients with concurrent cardiovascular problems of receiving this highly effective treatment. Here we present a treatment alternative with an elbasvir/grazoprevir regimen, based on our successful treatment of a patient under concurrent amiodarone therapy. Our observations indicate that patients treated with amiodarone can finally benefit from effective antiviral therapy.